Literature DB >> 22573913

Considerations in the design of clinical trials for cognitive aging.

Eric M Reiman1, Roberta Diaz Brinton, Russell Katz, Ronald C Petersen, Selam Negash, Dan Mungas, Paul S Aisen.   

Abstract

What will it take to develop interventions for the treatment of age-related cognitive decline? Session V of the Summit provided perspectives on the design of clinical trials to evaluate promising but unproven interventions, and some of the steps needed to accelerate the discovery and evaluation of promising treatments. It considered strategies to further characterize the biological and cognitive changes associated with normal aging and their translation into the development of new treatments. It provided regulatory, scientific, and clinical perspectives about neurocognitive aging treatments, their potential benefits and risks, and the strategies and endpoints needed to evaluate them in the most rapid, rigorous, and clinically meaningful way. It considered lessons learned from the study of Alzheimer's disease, the promising roles of biomarkers in neurocognitive aging research, and ways to help galvanize the scientific study and treatment of neurocognitive aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573913      PMCID: PMC3391068          DOI: 10.1093/gerona/gls124

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  18 in total

1.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

Authors:  Scott A Small; Monica K Chawla; Michael Buonocore; Peter R Rapp; Carol A Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

2.  Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics.

Authors:  Dan Mungas; Bruce R Reed; Paul K Crane; Mary N Haan; Hector González
Journal:  Psychol Assess       Date:  2004-12

3.  Regional network of magnetic resonance imaging gray matter volume in healthy aging.

Authors:  Gene E Alexander; Kewei Chen; Tricia L Merkley; Eric M Reiman; Richard J Caselli; Melaney Aschenbrenner; Laura Santerre-Lemmon; Diana J Lewis; Pietro Pietrini; Stefan J Teipel; Harald Hampel; Stanley I Rapoport; James R Moeller
Journal:  Neuroreport       Date:  2006-07-17       Impact factor: 1.837

4.  Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers.

Authors:  E Salmon; P Maquet; B Sadzot; C Degueldre; C Lemaire; G Franck
Journal:  Acta Neurol Belg       Date:  1991       Impact factor: 2.396

5.  Common Kibra alleles are associated with human memory performance.

Authors:  Andreas Papassotiropoulos; Dietrich A Stephan; Matthew J Huentelman; Frederic J Hoerndli; David W Craig; John V Pearson; Kim-Dung Huynh; Fabienne Brunner; Jason Corneveaux; David Osborne; M Axel Wollmer; Amanda Aerni; Daniel Coluccia; Jürgen Hänggi; Christian R A Mondadori; Andreas Buchmann; Eric M Reiman; Richard J Caselli; Katharina Henke; Dominique J-F de Quervain
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

6.  Application of item response theory for development of a global functioning measure of dementia with linear measurement properties.

Authors:  D Mungas; B R Reed
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

Review 7.  Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

Authors:  Jia Yao; Jamaica R Rettberg; Lauren P Klosinski; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Mol Aspects Med       Date:  2011-10-21

8.  Age-related alterations in white matter microstructure measured by diffusion tensor imaging.

Authors:  D H Salat; D S Tuch; D N Greve; A J W van der Kouwe; N D Hevelone; A K Zaleta; B R Rosen; B Fischl; S Corkin; H Diana Rosas; A M Dale
Journal:  Neurobiol Aging       Date:  2004-12-19       Impact factor: 4.673

9.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Douglas G Walker; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Gene E Alexander; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2006-10-31       Impact factor: 3.107

10.  Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.

Authors:  Liqin Zhao; Chunyang Jin; Zisu Mao; Madathil B Gopinathan; Kenneth Rehder; Roberta D Brinton
Journal:  J Med Chem       Date:  2007-08-14       Impact factor: 7.446

View more
  8 in total

1.  APOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging.

Authors:  Shannon K Runge; Brent J Small; G Peggy McFall; Roger A Dixon
Journal:  J Int Neuropsychol Soc       Date:  2014-05       Impact factor: 2.892

Review 2.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Authors:  Davis C Ryman; Natalia Acosta-Baena; Paul S Aisen; Thomas Bird; Adrian Danek; Nick C Fox; Alison Goate; Peter Frommelt; Bernardino Ghetti; Jessica B S Langbaum; Francisco Lopera; Ralph Martins; Colin L Masters; Richard P Mayeux; Eric McDade; Sonia Moreno; Eric M Reiman; John M Ringman; Steve Salloway; Peter R Schofield; Reisa Sperling; Pierre N Tariot; Chengjie Xiong; John C Morris; Randall J Bateman
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

Review 3.  Molecular aspects of age-related cognitive decline: the role of GABA signaling.

Authors:  Joseph A McQuail; Charles J Frazier; Jennifer L Bizon
Journal:  Trends Mol Med       Date:  2015-06-09       Impact factor: 11.951

Review 4.  Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities.

Authors:  Charles C Caldwell; Jia Yao; Roberta Diaz Brinton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

5.  Advances in designs for Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Heath Gould; Kate Zhong
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

6.  Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.

Authors:  Auriel A Willette; Vince D Calhoun; Josephine M Egan; Dimitrios Kapogiannis
Journal:  Psychiatry Res       Date:  2014-08-17       Impact factor: 3.222

7.  Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.

Authors:  Maja Mustapic; Erez Eitan; John K Werner; Sean T Berkowitz; Michael P Lazaropoulos; Joyce Tran; Edward J Goetzl; Dimitrios Kapogiannis
Journal:  Front Neurosci       Date:  2017-05-22       Impact factor: 4.677

8.  Thalamo-cortical inter-subject functional correlation during movie watching across the adult lifespan.

Authors:  Jinpeng Niu; Zihao Zheng; Ziqi Wang; Longchun Xu; Qingmin Meng; Xiaotong Zhang; Liangfeng Kuang; Shigang Wang; Li Dong; Jianfeng Qiu; Qing Jiao; Weifang Cao
Journal:  Front Neurosci       Date:  2022-09-21       Impact factor: 5.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.